Clinical outcomes of edoxaban treatment in atrial fibrillation patients with high bleeding risk: insights from the ETNA-AF-China 1-year follow-up
Event:
ESC Congress 2024
Topic:
Oral Anticoagulation
Session:
Oral anticoagulant therapy for atrial fibrillation in clinical practice
